Vaccines

23 Nov 2007 New data published in The Lancet show GSK's rotavirus vaccine Rotarix(R) offers sustained and broad protection against all common circulating rotavirus types
22 Nov 2007 Diamyd Executes Agreement With US National Institutes of Health For a Type 1 Diabetes Trial With The Experimental Diamyd(R) Diabetes Vaccine
22 Nov 2007 New promising results published on Pharmexa's PADRE(R) epitope in Alzheimer's vaccine
20 Nov 2007 Cytos Biotechnology presents encouraging phase IIa study results for its melanoma vaccine CYT004-MelQbG10
19 Nov 2007 Curalogic has commenced a Phase III clinical study with the grass product
19 Nov 2007 AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine to Enter Phase 1 Safety Study Funded by the NIH
19 Nov 2007 Pharmexa provides update on the HeptoVax trial of GV1001 in liver cancer
15 Nov 2007 Sanofi Pasteur and Acambis join forces to bring West Nile vaccine to market
15 Nov 2007 New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis
13 Nov 2007 AVAX Technologies announces the initiation of its Phase III Registration trial of M-Vax(R) in Metastatic Melanoma
12 Nov 2007 Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting
09 Nov 2007 Promising clinical results from new HIV vaccine
07 Nov 2007 Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
07 Nov 2007 Sanofi Pasteur initiates phase II trial of cell
06 Nov 2007 Presentation of phase IIa results for Cytos Biotechnology’s hypertension vaccine at the American Heart Association Scientific Sessions 2007
06 Nov 2007 GlobeImmune Announces Presentation of Results from a Randomized Phase 1b Study of the GI-5005 Tarmogen in Patients with Chronic Hepatitis C Infection
05 Nov 2007 Curalogic updates from its Phase III clinical study with the ragweed product
03 Nov 2007 IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
03 Nov 2007 IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients
02 Nov 2007 Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
24 Oct 2007 Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
19 Oct 2007 Sanofi Pasteur receives FDA approval of meningococcal vaccine for children
18 Oct 2007 Interim Safety Data Favorable for Vical's Phase 2 Trial of DNA Vaccine Against CMV
11 Oct 2007 Pharmexa provides update on the development of GV1001
09 Oct 2007 Amorfix Life Sciences develops two vaccines that extend life in Amyotrophic Lateral Sclerosis (ALS) animal model

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top